United Parcel Service Inc. Cl B (0R08)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 105.56 |
|---|---|
| 52-week range | 87.50 – 122.35 |
| Return, 1 month / 3 months | +13.4% / −5.3% |
| Return, 1 year / 3 years | +26.0% / −7.1% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -20.7% |
| Average daily value traded | 0.40M USD |
| Dividend yield | 6.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
United Parcel Service, commonly known as UPS, is a logistics company that delivers packages and freight for businesses and consumers around the world. It runs an integrated network of trucks, aircraft and sorting hubs, and offers supply chain services such as warehousing, customs brokerage and freight forwarding. The company is based in the United States and serves customers across many countries, from small businesses shipping parcels to large corporations managing complex distribution needs.
The shares are listed on the London Stock Exchange in UK under the code 0R08, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
United Parcel Service Inc. Cl B (0R08) trades on the London Stock Exchange in UK. It last closed at USD 105.56 on 27 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,589 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.0% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.9% | ||
| From 52-week high | -12.0% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | 0.9% | ||
| 12-month return, skipping the last month | 11.1% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.7% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.40M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.2% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +6.6% |
|---|---|
| 1 month | +13.4% |
| 3 months | −5.3% |
| 6 months | +0.9% |
| 1 year | +26.0% |
| 3 years | −7.1% |
| 5 years | −37.1% |
Signals
| 50-day / 200-day average | 98.97 / 102.55 |
|---|---|
| Golden / death cross (60 days) | Death, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Aug 2026 | USD 1.6400 |
| 15 May 2026 | USD 1.6400 |
| 16 Feb 2026 | USD 1.6400 |
| 14 Nov 2025 | USD 1.6400 |
| 15 Aug 2025 | USD 1.6400 |
| 16 May 2025 | USD 1.6400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.